✨
AI Summary
- J&J's Icotyde potential; Revolution's daraxonrasib data.
- Travere's Filspari for FSGS; GSK's B7-H4 ADC bet.
- Lilly leads global pharma sales; biopharma industry news.
Citeline Podcasts